Dr
AbbVie
Disclosure: AbbVie (Employee)
Timothy (TJ) Carrothers, ScD, is Director, Pharmacometrics, at AbbVie, where he leads the modeling and simulation activities supporting the development of anti-bacterial therapies, including dalbavancin, ceftaroline, ceftazidime-avibactam, and aztreonam-avibactam. He has 20 years of experience in the application of quantitative pharmacology, decision analytic, and innovative statistical approaches to the development of biopharmaceutics. He holds a Doctor of Science degree (Environmental Science and Risk Management) from the Harvard School of Public Health and MS and BS degrees from Stanford University. He is a Fellow of the American College of Clinical Pharmacology.